58 Neurologic-Event-Free Survival (NEFS): A New Endpoint for Severe Combined Immunodeficiency (SCID) Patients Diagnosed by Newborn Screening (NBS) and Treated with Hematopoietic Cell Transplantation (HCT).

Biology of Blood and Marrow Transplantation

Christopher C. Dvorak, Justin T. Wahlstrom, Jennifer Puck, Morna Dorsey, Alexis Melton, Biljana Horn, Morton J. Cowan. 58 Neurologic-Event-Free Survival (NEFS): A New Endpoint for Severe Combined Immunodeficiency (SCID) Patients Diagnosed by Newborn Screening (NBS) and Treated with Hematopoietic Cell Transplantation (HCT). . 2017 Mar 1; 23(3):s75.

2017

https://researcherprofiles.org/profile/79295150

Christopher C. Dvorak, Justin T. Wahlstrom, Jennifer Puck, Morna Dorsey, Alexis Melton, Biljana Horn, Morton J. Cowan

Acupressure for Childhood Cancer Symptom Management

Search form

You are here

58 Neurologic-Event-Free Survival (NEFS): A New Endpoint for Severe Combined Immunodeficiency (SCID) Patients Diagnosed by Newborn Screening (NBS) and Treated with Hematopoietic Cell Transplantation (HCT).